Chronic depression: Medication (Nefazodone) or psychotherapy (CBASP) is effective when the other is not

Archives of General Psychiatry

Volumn 62, Issue 5, 2005, Pages 513-520

  Schatzberg, Alan F ^a   Rush, A John ^b   Arnow, Bruce A ^a   Banks, Phillip L C ^c   Blalock, Janice A ^d   Borian, Frances E ^e   Howland, Robert ^f   Klein, Daniel N ^g   Kocsis, James H ^h   Kornstein, Susan G ⁱ   Manber, Rachel ^a   Markowitz, John C ^h   Miller, Ivan ^j   Ninan, Philip T ^k   Rothbaum, Barbara O ^k   Thase, Michael E ^f   Trivedi, Madhukar H ^b   Keller, Martin B ^j  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c i3STATPROBE Inc   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e BRISTOL MYERS SQUIBB   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g STONY BROOK UNIVERSITY   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁱ VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j BROWN UNIVERSITY   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NEFAZODONE;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FISHER EXACT TEST; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MCNEMAR TEST; MENTAL HEALTH CENTER; MONOTHERAPY; OUTCOMES RESEARCH; OUTPATIENT; PSYCHOTHERAPY; REMISSION; SIDE EFFECT;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHRONIC DISEASE; COGNITIVE THERAPY; CROSS-OVER STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TRIAZOLES;

EID: 20944433399     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.62.5.513     Document Type: Article

References (28)

1. Depression Guideline Panel. Depression in Primary Care: Treatment of Major Depression. Vol 2. Rockville, Md: Agency for Health Care Policy and Research, Public Health Service, Dept of Health and Human Services; 1993. Clinical Practice Guideline, No. 5, AHCPR Publication 93-0551.
2. Thase ME, Rush AJ. Treatment-resistant depression. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995:1081-1097.
3. Thase ME, Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry. 1997;58:23-29.
4. Rush AJ, Kupfer DJ. Strategies and tactics in the treatment of depression. In: Gabbard GO, ed. Treatment of Psychiatric Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2001:1417-1439.
5. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, Quitkin FM, Wisniewski S, Lavori PW, Rosenbaum JF, Kupfer DJ; for the STAR*D Investigators Group. Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Psychiatr Clin North Am. 2003; 26:457-494.
6. Stewart JW, Mercier MA, Agnosti V, Guardino M, Quitkin FM. Imipramine is effective after unsuccessful cognitive therapy: sequential use of cognitive therapy and imipramine in depressed outpatients. J Clin Psychopharmacol. 1993;13:114-119.
7. Rush AJ, Thase ME. Psychotherapies for depressive disorders: a review. In: Maj M, Sartorius N, eds. Depressive Disorders. Chichester, England: John Wiley & Sons Ltd; 1999:161-206. WPA Series: Evidence and Experience in Psychiatry, vol 1.
8. Thase ME, Rush AJ, Howland RH, Kornstein SG, Kocsis JH, Gelenberg AJ, Schatzberg AF, Koran LM, Keller MB, Russell JM, Hirschfeld RM, LaVange LM, Klein DN, Fawcett J, Harrison W. Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. Arch Gen Psychiatry. 2002;59:233-239.
9. McCullough JP Jr. Treatment for Chronic Depression: Cognitive Behavioral Analysis System of Psychotherapy (CBASP). New York, NY: Guilford Press; 2000.
10. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342:1462-1470.
11. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1995.
12. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II). Washington, DC: American Psychiatric Press; 1997.
13. Fawcett J, Epstein P, Fiester SJ, Elkin I, Autry JH. Clinical management-imipramine/placebo administration manual: NIMH Treatment of Depression Collaborative Research Program. Psychopharmacol Bull. 1987;23:309-324.
14. McCullough JP. Therapist Manual for Cognitive Behavioral Analysis System of Psychotherapy. Richmond: Virginia Commonwealth University; 1995.
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
16. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-296.
17. Miller IW, Bishop S, Worman WH, Maddever H. The modified Hamilton Rating Scale for Depression: reliability and validity. Psychiatry Res. 1985;14:131-142.
18. Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, Md: Psychopharmacology Research Branch, National Institutes of Health; 1976. Publication ADM 76-338.
19. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger JE, Burns CT. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res. 1986;18:65-87.
20. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med. 1996;26:477-486.
21. Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ, Markowitz JC, Schlager DS, Kornstein SG, Davis SM, Harrison WM, Keller MB. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline and imipramine. J Clin Psychiatry. 1998;59:608-619.
22. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP, Kunovac JL, Leon AC, Mueller TI, Rice JA, Keller MB. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry. 1998;55:694-700.
23. Paykel ES, Scott J, Teasdale JD, Garland A, Moore R, Jenaway A, Cornwall PL, Hayhursl H, Abbott R, Pope M. Prevention of relapse in residual depression by cognitive therapy. Arch Gen Psychiatry. 1999;56:829-835.
24. Koran LM, Gelenberg AJ, Kornstein SG, Howland RH, Friedman RA, DeBattista C, Klein D, Kocsis JH, Schatzberg AF, Thase ME, Rush AJ, Hirschfeld RM, LaVange LM, Keller MB. Sertraline versus imipramine to prevent relapse in chronic depression. J Affect Disord. 2001;65:27-36.
25. Joffe RT, Singer W, Levitt AJ, MacDonald C. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry. 1993;50:387-393.
26. McAskill R, Mir S, Taylor D. Pindolol augmentation of antidepressant therapy [published correction appears in Sr J Psychiatry. 1998;173:443]. Br J Psychiatry. 1998;173:203-208.
27. Landen M, Goran B, Agren H, Fahlen T. A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment refractory depression. J Clin Psychiatry. 1998;59:664-668.
28. Kocsis JH, Frances AJ, Voss C, Mann JJ, Mason BJ, Sweeney J. Imipramine treatment for chronic depression. Arch Gen Psychiatry. 1988;45:253-257.